2026-17528NoticeWallet

Trade war erupts over skin cancer prediction test knockoffs

Published Date: 8/27/2026

Notice

Summary

Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on July 10, 2026, under section 337 of the Tariff Act of 1930, as amended, on behalf of Castle Biosciences, Inc. of Friendswood, Texas. The complaint alleges violations of section 337 based upon the importation into the United States or in the sale of certain melanoma predictive and prognostic tests and components thereof by reason of unfair competition and unfair acts through false and misleading advertising, the threat or effect of which is to destroy or substantially injure an industry in the United States. The complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.

Analyzed Economic Effects

1 provisions identified: 0 benefits, 0 costs, 1 mixed.

Investigation Could Block Melanoma Tests

The U.S. International Trade Commission opened an investigation on August 25, 2026 (after a complaint filed July 10, 2026) into certain "melanoma predictive and prognostic CP-GEP tests and related components." If the Commission finds a violation, it could issue a limited exclusion order and cease and desist orders that would stop imports or sales of those specific tests in the United States.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Effective Date
Published Date
8/25/2026
8/27/2026

Department and Agencies

Department
Independent Agency
Agency
International Trade Commission
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register